Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem

Pembrolizumab-belzutifan combo improves disease-free survival in clear cell renal cell carcinoma
Treatment with pembrolizumab plus belzutifan results in a significant and clinically meaningful improvement in disease-free survival (DFS) compared with pembrolizumab monotherapy in patients with clear cell renal cell carcinoma (ccRCC) who are at greater risk of recurrence following nephrectomy, results from the phase III LITESPARK-022 study have shown.

Novel ingestible gastric balloon holds promise for weight loss
A study from Argentina shows the potential of an innovative ingestible gastric balloon, an intragastric device that does not require surgery, anaesthesia, or endoscopy, for weight management in individuals with obesity.

COVID shots moderately effective against postacute sequelae
COVID-19 vaccination appears to be moderately effective at preventing lingering symptoms following SARS-CoV-2 infection, and this effectiveness may increase with the number of doses administered, according to a meta-analysis.





